Transcranial Pulse Stimulation: Ultrasound That Reaches Deep Into the Brain

There's a Place in Your Brain You Can't Reach From the Outside. Until Now.

Buried about 5 centimeters beneath the surface of your skull, tucked inside the temporal lobe on each side of your brain, sit two small, curved structures called the hippocampi. They're each about the size of a seahorse (that's literally what "hippocampus" means in Greek), and they're arguably the most important structures in your brain for forming new memories.

When Alzheimer's disease begins its slow destruction, the hippocampus is one of the first places it attacks. The progressive loss of hippocampal neurons is what causes the early memory problems that characterize the disease. People forget recent conversations, then recent events, then the names of people they love.

Here's the frustrating part. For decades, neuroscientists have had non-invasive tools that can stimulate the brain from outside the skull. Transcranial magnetic stimulation (TMS) uses magnetic fields. Transcranial direct current stimulation (tDCS) uses weak electrical currents. Both can modulate neural activity. Both have shown therapeutic promise for depression, chronic pain, and other conditions.

But neither can reach the hippocampus. They're limited to the outer few centimeters of cortex. The deep brain is off-limits.

Or it was. Until researchers figured out how to use something you already know from medical imaging: ultrasound.

Transcranial pulse stimulation, or TPS, uses focused pulses of ultrasound energy that pass through the skull and converge on a target deep inside the brain. It can reach the hippocampus. It can reach the thalamus. It can reach structures that, until recently, you could only stimulate by opening the skull and inserting electrodes.

This is not science fiction. It's happening in clinics in Europe right now. And the early results are genuinely interesting.

A Quick Tour of Non-Invasive Brain Stimulation (And Why Most of It Stays at the Surface)

To understand why TPS matters, you need to understand the landscape it's entering.

Non-invasive brain stimulation, the practice of modulating brain activity from outside the skull, has been around since the early 2000s in its modern form. The two dominant approaches are TMS and tDCS.

Transcranial magnetic stimulation (TMS) places a magnetic coil against the scalp and generates a rapidly changing magnetic field. This field induces electrical currents in nearby neural tissue, causing neurons to fire. TMS is FDA-approved for treatment-resistant depression and has a substantial evidence base. The limitation is physics. Magnetic fields weaken rapidly with distance. By the time the field has penetrated 2 to 3 centimeters past the skull, it's too weak to reliably activate neurons. TMS is a cortical tool.

Transcranial direct current stimulation (tDCS) passes a weak electrical current (typically 1-2 milliamps) between two electrodes placed on the scalp. This current doesn't directly cause neurons to fire. Instead, it shifts the resting membrane potential of neurons in the path of the current, making them slightly more or less likely to fire in response to other inputs. tDCS is inexpensive and easy to administer, but the current diffuses broadly through tissue and, like TMS, is largely confined to cortical effects.

Both of these technologies have changed lives. TMS for depression is a genuine medical breakthrough. tDCS has a growing research base in cognitive enhancement, pain management, and stroke rehabilitation.

But neither can touch deep brain structures. The hippocampus, the amygdala, the basal ganglia, the thalamus, all the structures implicated in Alzheimer's, Parkinson's, and other neurological conditions that originate in the brain's interior, are beyond their reach.

This is why deep brain stimulation (DBS) still requires surgery. A neurosurgeon drills a hole in the skull, threads electrodes deep into the brain, and connects them to an implanted pulse generator. DBS is remarkably effective for Parkinson's disease and essential tremor, but it's brain surgery. It carries all the risks of an invasive procedure: infection, hemorrhage, and the irreducible danger of putting metal objects inside living brain tissue.

What the field has been looking for, really since the beginning, is a way to reach deep brain structures without opening the skull.

How TPS Works: Sending Sound Where Light and Magnets Can't Go

TPS uses ultrasound, which is mechanical energy, not electromagnetic. And that distinction makes all the difference.

Sound waves are pressure waves. They propagate through tissue by compressing and expanding the medium they travel through. Unlike magnetic fields, which weaken dramatically with distance through tissue, and unlike electrical currents, which diffuse broadly, focused ultrasound can be directed in a tight beam that maintains its energy over longer distances.

Here's a useful analogy. Imagine you're trying to push a beach ball across a swimming pool. If you splash water at it (broadly, diffusely), the waves spread out in every direction and barely move the ball. That's tDCS. If you throw a baseball at it from the edge of the pool, you have force but it drops off quickly. That's TMS. But if you could generate a water jet, a focused stream of pressure, you could push the ball from meters away with precision. That's TPS.

The specific physics of TPS work like this:

1. A handheld device generates very short ultrasound pulses, typically 3 to 5 microseconds each, at a low repetition rate (around 4-5 Hz).
2. These pulses are focused using the geometry of the ultrasound transducer so that they converge at a specific point inside the brain.
3. MRI-guided neuronavigation tells the operator exactly where to aim. Before the procedure, the patient gets an MRI scan. During the session, the clinician uses a navigation system to target specific brain structures, often the hippocampus.
4. At the focal point, the mechanical pressure waves create a brief micro-displacement in the tissue, on the order of micrometers.

This mechanical perturbation is believed to activate mechanosensitive ion channels on neurons. These channels respond to physical pressure by opening and allowing ions to flow, which changes the neuron's electrical state. The effect is neural stimulation driven by mechanical force rather than electromagnetic energy.

What the Clinical Evidence Shows

TPS is still an emerging technology, and it's important to be honest about where the evidence stands. It's promising. It's also early.

The most studied application is Alzheimer's disease. The pioneering clinical work has come from a team at the Medical University of Vienna, led by Roland Beisteiner. Their 2019 pilot study, published in Advanced Science, treated Alzheimer's patients with TPS targeting the hippocampus and other memory-related structures. Patients received six sessions over two weeks.

The results were cautiously encouraging. Patients showed improvements on neuropsychological tests measuring memory, attention, and executive function. Functional MRI scans taken before and after treatment showed increased connectivity in brain networks associated with memory. The effects persisted for at least three months after the final session.

A subsequent larger study, and several independent replications, have shown similar patterns. Improvements are modest but measurable. Patients don't suddenly recover lost memories, but their rate of cognitive decline appears to slow, and some specific cognitive functions improve.

Here's what researchers think is happening at a biological level. The mechanical stimulation from TPS may:

• Increase local blood flow to the targeted region
• Promote the release of brain-derived neurotrophic factor (BDNF), a protein critical for neuronal survival and growth
• Modulate neuroinflammation, which is increasingly recognized as a key driver of Alzheimer's progression
• Enhance synaptic plasticity in surviving neurons, essentially helping the remaining brain tissue work more efficiently

None of these mechanisms is fully confirmed yet. This is an active area of research with multiple labs working to understand exactly how mechanical pressure waves translate into therapeutic neural effects.

The Neurosity Crown gives you real-time access to your own brainwave data across 8 EEG channels at 256Hz, with on-device processing and open SDKs.

See the Crown

TPS vs Other Brain Stimulation Methods: Which Is Better?

To put TPS in context, here's how it compares to the other major non-invasive brain stimulation techniques.

The most striking thing about this comparison is the depth advantage. TPS is the only non-invasive method that can reliably stimulate deep brain structures. That's not an incremental improvement. It's a categorical difference. Conditions that originate in subcortical areas, Alzheimer's, Parkinson's, certain types of epilepsy, severe treatment-resistant depression, have been beyond the reach of non-invasive stimulation until now.

What TPS Cannot Do (And Honest Limitations)

It's just as important to understand what TPS can't do as what it can.

It's not a cure for Alzheimer's. The cognitive improvements seen in clinical trials are real but modest. Alzheimer's involves massive, progressive neuronal death. TPS may slow decline and improve function in surviving networks, but it doesn't reverse the underlying disease process. No stimulation technique does.

It requires MRI guidance. This isn't something you can do at home. Each session requires neuronavigation to target the ultrasound pulses accurately. Getting the focal point wrong by even a centimeter means you're stimulating the wrong structure. This requirement limits TPS to clinical settings with expensive equipment and trained operators.

Long-term safety data is still accumulating. TPS has been used clinically for several years now, primarily in Europe, and the safety profile looks good. But "several years" is not a long time in medicine. We don't yet have data on what happens after five or ten years of repeated TPS sessions. The absence of observed harm is encouraging, but it's not the same as confirmed long-term safety.

The mechanism isn't fully understood. We know TPS does something. We can measure the effects on functional connectivity, on neuropsychological test scores, on blood flow. But the precise chain of events from "ultrasound pulse hits tissue" to "patient performs better on memory test" is still being worked out. This is actually normal for brain stimulation. We don't fully understand how TMS treats depression either, and it's been FDA-approved for years.

It doesn't provide any information about the brain. This is a critical distinction. TPS is a stimulation technique, not an imaging or measurement technique. It changes brain activity. It doesn't tell you what brain activity looks like. To know what's actually happening in the brain, before, during, and after stimulation, you need a measurement tool like EEG.

Where TPS Fits in the Future of Brain Technology

The story of brain technology in the 21st century is the story of convergence. Measurement tools are getting better. Stimulation tools are getting better. AI is getting better at interpreting neural data. And the walls between these categories are starting to dissolve.

Consider this trajectory. EEG devices like the Neurosity Crown can now measure brain activity in real time from the comfort of your desk, with 8 channels, 256Hz sampling, and on-device processing through the N3 chipset. The data streams through open SDKs into applications that can respond to your cognitive state in real time. That's the measurement side.

On the stimulation side, TPS and transcranial focused ultrasound are proving that we can reach brain structures previously accessible only through surgery. The precision is improving. The protocols are being refined. The evidence base is growing.

Now imagine these two capabilities converging. A world where real-time brain measurement informs targeted stimulation. Where EEG data identifies which neural circuits are underperforming, and focused ultrasound delivers precisely calibrated stimulation to the right structures at the right time. Where the measurement device and the stimulation device talk to each other in a closed loop, continuously optimizing the intervention based on the brain's response.

We're not there yet. But the pieces are falling into place faster than most people realize.

For now, the most useful thing you can do is start understanding your own brain. That means measurement. That means data. And the remarkable thing about this moment in history is that you don't need to visit a hospital to get it. Consumer EEG devices can give you real-time insight into your own neural dynamics, your focus patterns, your sleep architecture, your cognitive performance across the day.

TPS represents the leading edge of what stimulation can do. But stimulation without measurement is flying blind. The future belongs to people who can see what their brain is doing and, increasingly, do something about it.

The Convergence Is Coming

Twenty years from now, the distinction between "brain measurement" and "brain stimulation" may seem as quaint as the distinction between "mobile phone" and "camera" seems today. The devices will converge. Measurement will inform stimulation in real time. Stimulation protocols will be personalized to individual neural architectures measured by EEG and other tools.

TPS is a piece of that future. It proves that we can reach deep brain structures safely and non-invasively. It proves that mechanical energy can modulate neural activity. And it opens a door that, once opened, will never close again.

The brain has been running largely unmonitored and unoptimized for the entire history of our species. That era is ending. First we learned to listen to it. Then we learned to read its signals. Now we're learning to speak its language.

The conversation between humans and their own brains is just getting started.